Drug Discovery Informatics for Big Pharma: Key Webinar Insights
Collaborative Drug
MARCH 21, 2025
The pharmaceutical R&D landscape continues to evolve rapidly with advances in computational technologies and artificial intelligence.
Drugs Pharmaceuticals Webinar 
Free Webinar on "Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules
Drug Discovery Today
JUNE 11, 2020
Webinar information:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PBMs and the Battle Over Patient Support Funds:Accumulators, Maximizers, and Alternative Funding (NEW Live Video Webinar)
Drug Channels
MAY 22, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. to 1:30 p.m.
Pharmacy 
97
97 
Follow the Vial: The Buy-and-Bill System for Distributing and Reimbursing Provider-Administered Outpatient Drugs (rerun)
Drug Channels
APRIL 21, 2022
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBM Industry Update: Trends, Controversies, and Outlook. By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. d/b/a Drug Channels Institute.
Pharmacy 98
98 
Available for Preorder: The 2021-22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels
SEPTEMBER 14, 2021
On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. to 1:30 p.m.
Drug Wholesalers and Brand-Name Drug Prices: Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s
Drug Channels
DECEMBER 5, 2023
Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach. to 1:30 p.m.
Pharmacy 98
98 
The 340B Drug Pricing Program: Trends, Controversies, and Outlook (NEW Live Video Webinar)
Drug Channels
MAY 21, 2024
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.
Pharmacy 52
52 
Follow the Vial: The Buy-and-Bill System for Distributing and Reimbursing Provider-Administered Outpatient Drugs
Drug Channels
OCTOBER 25, 2021
By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar.
Pharmacy 97
97 
Who Will Pay for Prescription Drugs in 2030? (Hint: It’s Us) (rerun)
Drug Channels
JULY 29, 2022
This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. d/b/a Drug Channels Institute.
Pharmacy 98
98 
Who Will Pay for Prescription Drugs in 2030? (Hint: It’s Us)
Drug Channels
APRIL 12, 2022
As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. One bright spot: consumers will account for an ever-smaller share of drug spending. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S.
Pharmacy 98
98 
NOW AVAILABLE: 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels
OCTOBER 8, 2024
I am pleased to announce Drug Channels Institute's new 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. pharmaceutical distribution industry. Please contact us if you did not receive your email.
The Economics of Copay Accumulators, Maximizers, and Alternative Funding Programs (Video) (rerun)
Drug Channels
OCTOBER 5, 2023
This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. In the video excerpt below, I describe these new approaches that plans offset specialty drug expenses. d/b/a Drug Channels Institute.
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels
APRIL 1, 2024
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. Click here to see the original post from December 2023.
Pharmacy 98
98 
Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap
The Strateos Blog: Drug Discovery
AUGUST 16, 2021
On July 20th, Strateos hosted a webinar entitled Drug Discovery and Medicinal Chemistry in the Era of Automation. Join us September 15th 8am PST for Part 2 of our Chemistry Webinar Series highlighting our extended features with PerkinElmer. To register for the webinar, click here. Daniel Rines, Ph.D.,
How CVS Health Drives Cardinal Health’s Distribution Financials
Drug Channels
SEPTEMBER 9, 2021
In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. d/b/a Drug Channels Institute. to 1:30 p.m.
How CVS Health Drives Cardinal Health’s Distribution Financials (rerun)
Drug Channels
DECEMBER 16, 2021
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2022. In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. drug purchaser. d/b/a Drug Channels Institute.
Webinar: Assessing Cognition Impairment Using Driving Simulators in Clinical Trials
Alta Sciences
FEBRUARY 8, 2024
The FDA guidance, Evaluating Drug Effects on the Ability to Operate a Motor Vehicle , indicates that testing in early-phase clinical development should emphasize sensitivity over specificity in CNS effects. In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.
HPM Director Dara Katcher Levy to Present Webinar on AMCP Format for Formulary Submissions v5.0
FDA Law Blog: Biosimilars
JUNE 24, 2024
HPM) Director Dara Katcher Levy will present an informative webinar on the newly released AMCP Format for Formulary Submissions version 5.0. To register for this insightful webinar, visit AMCP Learn. This afternoon Hyman, Phelps & McNamara, P.C.
White Bagging Update 2023: Saving Money or Shifting Costs? (rerun)
Drug Channels
DECEMBER 13, 2023
This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. Time for our annual update on the channels for provider-administered drugs. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
[Webinar] How biotech companies can improve clinical supply planning and distrib…
The Pharma Data
SEPTEMBER 15, 2020
Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
MAY 24, 2023
In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. to 1:30 p.m.
Pharmacy 98
98 
Gross-to-Net Bubble Update: 2021 Pricing Realities at 10 Top Drugmakers (rerun)
Drug Channels
JULY 28, 2022
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. That’s why I refer to them as drug pricing flat earthers (#DPFE).
Gross-to-Net Bubble Update: 2022 Pricing Realities at 10 Top Drugmakers
Drug Channels
JUNE 13, 2023
Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. to 1:30 p.m.
Warped Incentives Update: The Gross-to-Net Bubble Exceeded $200 Billion in 2021 (rerun)
Drug Channels
JULY 26, 2022
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. More than $122 billion in "savings" (offsets) from the current drug pricing reconciliation legislation comes from blocking rebate reform—which never even happened.
Developing and Manufacturing Minitablets to Extend Drug Lifecycle
Fierce BioTech
JANUARY 12, 2024
Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.
Drugs 52
52 
Leveraging Whole-Genome Sequencing for Advanced Drug Discovery
Fierce BioTech
SEPTEMBER 13, 2024
Key Takeaways: Translating Genetic Insights into Clinical Success: Drug targets with genetic evidence are known to have a much higher chance of succeeding. Join us as we explore how these data resources are driving the next generation of pharmaceutical development. Listing Image NashBio-Logo-Listing-New-10232024.png
Drugs 52
52 
Harnessing AI and Real-World Data: The Future of Clinical Development
PPD
SEPTEMBER 16, 2024
The pharmaceutical industry is currently experiencing a significant transformation. The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. AI is also proving useful in drug repurposing or indication selection.
New Solutions for Aseptic Filling for Gene Therapy
Fierce BioTech
MAY 2, 2024
West Pharmaceutical Services (West) and Cytiva have teamed up to offer innovative and versatile fill finish solutions to efficiently meet the unique demands of advanced pharmaceutical applications. In this webinar, you will learn about: The challenges and risks related to the packaging and filling of high-value drug products.
Therapies 52
52 
Learning the Lessons of Failure: How to improve the economics of Life Sciences R&D
Fierce BioTech
MARCH 4, 2024
What you'll learn: Explore the significant costs associated with failed drug and device launches, and the impact on pharmaceutical companies. Gain insights from real-world examples of drugs and devices such as bortezomib (Velcade), inhaled insulin (Exubera), Ionapegsomatropin (Sytrofa) and many more. Click here to login.
Science 52
52 
Organofluorine Chem in Pharma Intermediates & APIs
Fierce BioTech
SEPTEMBER 6, 2023
Organofluorine Chem in Pharma Intermediates & APIs swheeler Wed, 09/06/2023 - 12:54 Wed, 10/18/2023 - 11:00 Resource Type Webinar Dr. Yuanqiang Li Dr. Pete Newsome Peter Halkjaer-Knudsen Duration 60 minutes Topics Covered: Introduction to Organofluorine Chemistry and its significance in pharmaceuticals.
AI At The Frontier: Empowering Early Career Professionals In Drug Discovery
Elrig
APRIL 29, 2024
Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?
How Pharma-Funded Groups Lie About Personal Drug Imports
Policy Prescription
MAY 28, 2021
For the past decade, I’ve written extensively about my view that pharma-funded organizations and initiatives are responsible for misleading Americans about the safety of buying more affordable prescription drugs over the Internet for import from Canada and other countries. Here’s one example and you can be the judge.
Pharmacy 52
52 
Pharma 4.0: How Networked Digital Technologies and Advanced Automation are Reshaping the Pharmaceutical Value Chain
The Connected Lab
JUNE 2, 2021
Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making.
Streamlining Clinical Development: Empowering Life Sciences with Automation
Fierce BioTech
JULY 19, 2023
From drug discovery to study conduct, industry experts will delve into key areas of transformation, including study start-up, study design, and process optimization. Accelerating time to treatment. Drive operational efficiencies. Achieve superior customer experiences. Click here to login. Listing Image Appian-LogoListing-9142023.png
ELRIG Appoints Dr Del Trezise as Chair
Elrig
APRIL 7, 2025
ELRIG Appoints Dr Del Trezise as Chair ELRIG Appoints Dr Del Trezise as Chair New leadership to drive continued growth and collaboration in drug discovery Cambridge, UK, 08 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board.
Transforming The DMTA Cycle Through Enhanced Collaboration
Fierce BioTech
JULY 14, 2023
This webinar is relevant to R&D business leaders, computational and medicinal chemists within the pharmaceutical and biotechnology sectors. It will explore the impact of selecting appropriate technology solutions on a business, enabling improved insights, a competitive edge, and faster progression through the drug discovery pipeline.
The Battle for Oncology Margin: How Private Equity Enables Vertical Integration by Pharmaceutical Wholesalers (rerun)
Drug Channels
DECEMBER 14, 2023
This week, I’m rerunning some popular posts while I prepare for tomorrow’s Drug Channels Outlook 2024 live video webinar. These financial firms have assembled significant oncology practice management companies that are primed for purchase by drug channel participants. d/b/a Drug Channels Institute.
Innovation in container closer systems and aseptic processing for ATMPs
Fierce BioTech
JANUARY 3, 2025
This joint webinar presentation by West and Groninger, explores the unique challenges of Cell and Gene Therapies, mRNA LNP therapeutics particularly regarding cold storage requirements and their impact on packaging solutions.
Packaging 52
52 
Innovations in aseptic processing for container closure systems
Fierce BioTech
JANUARY 3, 2025
Innovations in aseptic processing for container closure systems dwunderlin Fri, 01/03/2025 - 14:26 Wed, 02/12/2025 - 10:00 Resource Type Webinar Jim Thompson Julian Petersen Duration 60 Minutes The pharmaceutical landscape is shifting from blockbuster drugs to personalized treatments, driving the need for innovative container closure systems.
Packaging 52
52 
Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis (rerun)
Drug Channels
OCTOBER 2, 2024
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. Fein, Ph.D.,
Pharmacy 52
52 
Six Crucial Trends Facing U.S. Drug Wholesalers
Drug Channels
DECEMBER 1, 2020
During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. distribution channels for prescription drugs. Pharmaceutical wholesalers have maintained shipments and operational capacity. drug wholesaling industry. d/b/a Drug Channels Institute. to 1:15 p.m.
Pharmacy 40
40 
Achieve Enhanced API Formulation Development Using This Technique
Alta Sciences
FEBRUARY 21, 2024
Poorly soluble active pharmaceutical ingredients (APIs) made from hydrophobic, amorphous-solid, or crystalline-type materials are highly manageable when you opt for nanomilling ― a complex and game-changing process that pulverizes and stabilizes particles.
Ensuring Patient Safety: Decoding FDA’s Rating System for CDMOs
Fierce BioTech
OCTOBER 16, 2023
png Listing Introduction Learn the pathway to excellence in pharmaceutical manufacturing. We will also delve into the possible challenges that CDMOs will face in achieving high scores and the steps to overcome those challenges, ensuring they deliver high-quality products. Click here to login. Listing Image Curia_ListingLogo_250x190.png
FDA 52
52 
The Pharmacist in the Value-Based Care Era
Fierce BioTech
MARCH 29, 2024
Is your pharmacy ready to make the leap? Click here to login. Listing Image Inovalon Logo.png Listing Introduction Pharmacists are being called to operate at the top of their license to close gaps in care.
Pharmacy 52
52 
Let's personalize your content